Genetics

Identification of microdeletions in the AZF region of the Y chromosome: AZFa (sY84, sY86); AZFb (sY127, sY134); AZFc (sY254, sY255). The presence of microdeletions in the AZF region of the Y chromosome causes dysfunction of proteins responsible for proper sperm production and may be a contributing factor to male infertility.

Identification of mutations in the patient's genetic material that predispose to thrombosis. The test includes identification of mutations in the Factor V (F5) gene, the Prothrombin (F2) gene, and the MTHFR gene polymorphism.

Identification of mutations predisposing to thrombosis in the patient's genetic material. The test includes the identification of mutations in the Factor V gene (F5), mutations in the Prothrombin gene (F2), and polymorphisms in the MTHFR gene.

Identification of mutations predisposing to thrombosis in the patient's genetic material. The test includes identification of mutations in the Factor V (F5) gene, mutations in the Prothrombin (F2) gene, and polymorphisms in the MTHFR gene.

Identification of MTHFR Gene Polymorphism in the Patient's Genetic Material

Identification of mutations in the Prothrombin (F2) gene in the patient's genetic material.

The HPV and CINtec Plus test enables the detection of neoplastic changes at the cellular stage, which are in the very early stages of development. This allows for the localization of cells where the normal cycle has been disrupted due to infection with high-risk human papillomavirus (HPV).

The HPV and CINtec Plus test enables the detection of neoplastic changes at the cellular stage, which are in the very early stages of development. This allows for the localization of cells where the normal cycle has been disrupted due to infection by high-risk human papillomavirus (HPV).

Identification of mutations in the Factor V (F5) gene in the patient's genetic material, commonly known as the Leiden V mutation.

Test Package Consisting of: CINtec PLUS p16/Ki67, Liquid-Based Cytology (LBC), HPV14.